610TiPA randomized Phase 2 study comparing different dosing approaches of induction treatment (first cycle) of regorafenib in metastatic colorectal cancer (mCRC) patientsG. Argilés Martinez,Enrique Sanz-Garcia,M. Valladares-Ayerbes,Jose María Vieitez,P. Garcia-Alfonso,C. Gravalos,M. Tobeña, G. Duran Ogaya,M.T. Cano Osuna,B. García-Paredes,C. Santos, M. Rodríguez-Garrote,F. Rivera Herrero,M.J. Safont,Alfredo Falcone,Fortunato Ciardiello,R. Goldberg,J. Bennouna,Josep Tabernero, E. Aranda AguilarAnnals of Oncology（2017）引用 0|浏览54暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
